Expanding Our Vision INRhode Island
Rhode Island is a vital hub for New England's biomanufacturing industry, and we're excited to grow our presence in Smithfield.
Our State-of-the-ArtFacility
We're expanding our legacy in regenerative medicine at 100 Technology Way, a cutting-edge biomanufacturing facility designed to support our industry-leading portfolio of advanced wound care products.
Our Impact onRhode Island
New England is our home, and our investment in Smithfield strengthens our ties to the region. We're driving economic growth, fostering collaboration, and creating exciting career opportunities in biotech, biomanufacturing, and research.
Impact Data Coming Soon
AboutOrganogenesis
Organogenesis Holdings Inc. is a leading regenerative medicine company developing, manufacturing, and commercializing advanced solutions for wound care, surgical applications, and sports medicine. We offer a comprehensive portfolio of innovative regenerative products that support patients across the continuum of care.